Problem statement: Answer the MCQ question.
Question: Which compound exhibits a 17.002\% hERG inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any other words.
Options:
a) Cc1cc(C)c2c(N)c(-c3nc4ccccc4[nH]3)sc2n1
b) Cc1cc(NC(=O)c2ccc3c(c2)OCCO3)ccc1NC(=O)c1ccco1
c) CCn1c(=S)sc2c(=O)n(-c3ccccc3)c(SC)nc21
d) CCC(NC(=S)NCc1ccc(F)cc1)c1ccc(C(C)C)cc1
Answer: a. Cc1cc(C)c2c(N)c(-c3nc4ccccc4[nH]3)sc2n1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1cc(C)c2c(N)c(-c3nc4ccccc4[nH]3)sc2n1
Cc1cc(C)c2c(N)c(-c3nc4ccccc4[nH]3)sc2n1
2-(1H-benzimidazol-2-yl)-4,6-dimethylthieno[2,3-b]pyridin-3-amine